Oncology Venture, Innovation & Partnering Summit 2024 官方网站

连接投资者和商界领袖，加速肿瘤领域的创新

本次会议是一个有高级投资者、公司高管、企业家和商业领袖参加的特别活动。在轻松的人际交流环节中，您可以与未来的投资者和合作伙伴接触。在行业主导的小组讨论中，您将获得关于癌症治疗和诊断的资金筹集活动、目标和业务发展的战略洞见。此外，在充满活力的炉边谈话中，您还可以听到肿瘤行业意见领袖的直率见解和商业建议，请您绝对不可错过。

Cambridge Innovation Institute是组织涵盖癌症治疗药物和诊断药物开发各方面最尖端会议具有长达30年经验的企划组织，基于该傲人的实绩，我们将举办一个专注于癌症领域业务发展的重要会议。本次会议将于2024年10月9日至10日在麻萨诸塞州剑桥市举行。这是CII新设立的Cambridge VIP部门的一部分，该活动将吸引高级投资者、公司高管和肿瘤领域创新创业的领导者来此聚集。这次高水平的网络交流活动由启发性的行业主导型小组讨论和炉边谈话组成，此外还提供了多个人际交流机会，让创业者、投资者和潜在的企业收购者能够建立有意义的人脉。参加本次会议，您将获得关于业务合作、投资和公司战略的宝贵战略洞见、直率的展望和实用的商业建议。

会议特色：

独家招待会和社交活动让您可与投资者、首席执行官和制药企业领袖互动。
透过小组讨论从肿瘤学业务领导者那里获得可行的见解。
在轻松的氛围中进行炉边谈话，您可以向肿瘤学高管学习并制定业务成功策略。
在主题限定的座谈会上，与潜在的未来合作伙伴和投资者一起开创最及时话题的新天地。
参加我们的年度会议，加速癌症创新！

Cambridge VIP Attendee Demographics

2024年议程主题：

Future opportunities in oncology investments and strategies to de-risk
肿瘤学领域的未来投资和风险规避策略
Emerging oncology therapeutics and modalities: radiopharmaceuticals, antibody-drug conjugates, CAR T-cell therapy, etc.
抗癌新药及方法：放射性药物、抗体偶联物、CAR-T细胞疗法等
Policy implications affecting oncology investors and operators: Inflation Reduction Act, BIOSECURE Act, and an upcoming election
政策对癌症业界投资者和高管的影响：《通胀削减法案》（IRA）、《生物安全法案》和即将举行的选举
Cancer diagnostics, screening, and early detection
癌症诊断、筛查和早期发现

Where does Artificial Intelligence add value in oncology: from discovery to care delivery?
从发现到提供护理，人工智慧在肿瘤学领域的价值体现在哪里？
Big pharma perspective on oncology venture, partnering, and M&A
大型制药公司对肿瘤风险投资、合作伙伴关系和并购的看法
Is “precision medicine” working?
“精准医疗”有效吗？
Innovation in oncology clinical trials
癌症临床试验的新突破
Improving oncology care delivery and health equity
改善癌症护理服务和健康公平
Ups and downs of immuno-oncology
免疫肿瘤学的兴衰
How to deliver value-based care in oncology?
如何在肿瘤学领域提供基于价值的照护(value-based care)？

顾问委员会

Mara Aspinall

Partner, Illumina Ventures

Christiana Bardon, MD

Co-Managing Partner, MPM BioImpact

Andrea Bild, PhD

Program Manager, Advanced Research Projects Agency for Health (ARPA-H)

Derek DiRocco

Partner, RA Capital Management

Keith J. Figlioli

Managing Partner, LRVHealth

Ben Freeberg

Founder and Managing Partner, Oncology Ventures

Luba Greenwood

Managing Partner, Binney Street Capital, Dana-Farber Cancer Institute

Gregory Grunberg, MD

Head, Life Sciences (North America), Temasek

Sofia Guerra

Vice President, Bessemer Venture Partners

David Hirsch, MD, PhD

CEO, Alpha-9 Oncology

Karen Hong, PhD

Co-Founder and Co-Owner, Cold Spring Bio

Rachel Humphrey, MD

President and Founding CEO
Normunity

Roger Kitterman

Senior Vice President, Ventures and Business Development & Licensing and Managing Partner, Mass General Brigham Ventures

Selin Kurnaz, PhD

Co-Founder and CEO, Massive Bio

Manoja Lecamwasam, PhD

System Vice President, Intellectual Property and Life Sciences Innovation, CommonSpirit Health

Matt McAviney, MD

Partner, NEA

Marie-Claire Peakman, PhD

Partner, Pfizer Ventures; Executive Director, Worldwide Business Development, Pfizer

Chevon Rariy, MD

Chief Health Officer and Senior Vice President, Digital Health, Oncology Care Partners

Maya R. Said, ScD

Founder and CEO, Outcomes4Me

Ajit Singh, PhD

Partner, Artiman Ventures

Dave Stevenson

COO & Managing Director, Merck Global Health Innovation Fund

Shaquille Vayda

Principal, Lux Capital

Carrie Williams

Vice President and Partner, McKesson Ventures

Darshana Zaveri

Founder and Managing Partner, Catalyst Health Ventures

查看全部 »

Cambridge VIP Events Testimonials

“Always a highlight of my summer now is coming in for DHIS. I liked the sessions a lot and thought they were informative. I think you are hitting all the right topics, and I like that it is the right size crowd and venue. Nothing to change from my end.”

SVP Retail Health, CVS Health

“It was my first SCOPE Investor and Innovation Conference and it was such an eye-opening event to meet talents with very different background to discuss the achievement and future gaps in Clinical Research, Digital Health, Health Service Providers. The network opportunity is amazing!”

PhD, Managing Director, Boehringer Ingelheim Venture Fund

“A fantastic event in Minneapolis. The conversations surrounded the critical subjects in the medtech environment that are critical to the ongoing success of our industry. Great to see old friends and make new ones. If you did not have the chance to attend, check in for next year, great city, great people, and fantastic network.”

CEO, The Mullings Group

“Medtech MVP brings together thought leaders, top investors, and companies for a day and a half packed agenda on medtech and healthtech topics. Top great quality speakers provided valuable information that I can use in my day to day.”

Director, Managing Director, HSBC

“Incredibly informative presentations on responsible use of generative AI, women and families’ health and CVS’ healthcare ecosystem.”

Global Medical Affairs, Oncology Innovation in Care Lead, AstraZeneca

"DHIS West covered extremely timely and relevant topics, in an intimate collegial setting. It's a beautiful venue for networking as well, with lots of indoor and outdoor spaces to connect - rare in the winter! ”

Co-Founder & CEO, Cortica